BIOMAT Database Logo BIOMAT Database Logo

Discrepant fibrinogen values during thrombolytic therapy--a reply. 1984

J J Dicht, and P A Roche

UI MeSH Term Description Entries
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J J Dicht, and P A Roche
Confirmation of Dr. Bick's finding of discrepant fibrinogen values during thrombolytic therapy.
March 1984, American journal of clinical pathology,
J J Dicht, and P A Roche
Discrepant fibrinogen values during thrombolytic therapy. Comparison of aca and Data-Fi results using immunofixation. Electrophoresis as a reference.
October 1985, American journal of clinical pathology,
J J Dicht, and P A Roche
Fibrinogen proteolysis and coagulation system activation during thrombolytic therapy.
January 1990, Advances in experimental medicine and biology,
J J Dicht, and P A Roche
alpha 2-Antiplasmin consumption and fibrinogen breakdown during thrombolytic therapy.
January 1979, Thrombosis research,
J J Dicht, and P A Roche
Automated nephelometry of fibrinogen: analytical performance and observations during thrombolytic therapy.
October 1988, Clinical chemistry,
J J Dicht, and P A Roche
Coupled D dimer and fibrinogen levels during thrombolytic therapy of venous thromboembolism.
February 1992, Thrombosis research,
J J Dicht, and P A Roche
Urinary fibrin-fibrinogen degradation products (FDP) in renal diseases and during thrombolytic therapy.
October 1973, Scandinavian journal of clinical and laboratory investigation,
J J Dicht, and P A Roche
[The significance of changes in fibrinogen levels during thrombolytic therapy in myocardial infarct].
March 1991, Vnitrni lekarstvi,
J J Dicht, and P A Roche
Combined effects of urokinase and heparin on PTT values during thrombolytic therapy.
February 1993, Angiology,
J J Dicht, and P A Roche
Discrepant INR values strike again.
January 1991, Clinical and laboratory haematology,
Copied contents to your clipboard!